The biology and medicinal chemistry of epothilones.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Medicinal Chemistry - Anti-Cancer Agents

• Publication date

  2012-11-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/1568011023354489PMID 12678754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Epothilone B stabilizes microtubules via Tau to protect retinal ganglion cells and promote axon regeneration.

  2026cites this paper
• A Review on the Microtubule Inhibitory Effects of Active Ingredients Extracted from TCMs and Ethnic Medicines in Cancer Treatment.

  2025cites this paper
• Epothilones as Natural Compounds for Novel Anticancer Drugs Development

  2023cites this paper
• Implication of metabolomics and transporter modulation based strategies to minimize multidrug resistance and enhance site-specific bioavailability: a needful consideration toward modern anticancer drug discovery

  2022cites this paper
• Epoxides: Developability as active pharmaceutical ingredients and biochemical probes.

  2022cites this paper
• Tau and Alzheimer’s Disease: Molecular Mechanisms and Treatment Approaches

  2021cites this paper
• Epothilones A and B: The 16-Membered Natural Macrolides as a Fascinating Template for Antibreast Cancer Drug Discovery

  2021cites this paper
• Development of novel derivatives of stilbene and macrocyclic compounds as potent of anti-microtubule factors.

  2021cites this paper
• Synthesis & Anticancer Evaluation of New Substituted 2-(3,4- Dimethoxyphenyl)benzazoles.

  2019cites this paper
• Highlights of Natural Products in Prostate Cancer Drug Discovery

  2019cites this paper
• Synthesis of the C1–C13 fragment of eribulin mesylate

  2019cites this paper
• Continuous low-dose infusion of patupilone increases the therapeutic index in mouse and rat tumour models

  2018cites this paper
• 21 Highlights of Natural Products in Prostate Cancer Drug Discovery

  2018cites this paper
• Chemotherapy and HER2-Directed Therapy for Metastatic Breast Cancer

  2018cites this paper
• Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.

  2017influential citation
• A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study.

  2017cites this paper
• A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcom a of the uterus, an NRG Oncology/Gynecologic Oncology Group study ☆

  2017cites this paper
• Patupilone-loaded poly(L-glutamic acid)-graft-methoxy-poly(ethylene glycol) micelle for oncotherapy

  2017cites this paper
• Exploring the Boundaries of "Practical": De Novo Syntheses of Complex Natural Product-Based Drug Candidates.

  2017cites this paper
• Synthesis and Biological Evaluation of Some Novel Isoxazole Derivatives

  2017cites this paper
• Targeting PAM signaling pathway in the treatment of pancreatic ductal adenocarcinoma

  2017cites this paper
• Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities

  2016cites this paper
• Chapter 9 – Anticancer Drugs Targeting Tubulin and Microtubules

  2015cites this paper
• Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?

  2015cites this paper
• Chemistry and Biology of Epothilones

  2014cites this paper
• Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma

  2014cites this paper
• Genome-based approaches for the diagnosis of breast cancer: a review with perspective

  2014cites this paper
• The Impact of Cyclopropane Configuration on the Biological Activity of Cyclopropyl‐Epothilones

  2014cites this paper
• Building blocks for (C15−C3)-modified epothilone D analogs

  2014cites this paper
• Epothilones: From discovery to clinical trials.

  2014cites this paper
• Development of other microtubule-stabilizer families: the epothilones and their derivatives

  2014cites this paper
• One-pot, four-component synthesis of novel cytotoxic agents 1-(5-aryl-1,3,4-oxadiazol-2-yl)-1-(1H-pyrrol-2-yl)methanamines.

  2014cites this paper
• Aziridine Alkaloids: Origin, Chemistry and Activity 30

  2013cites this paper
• A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer.

  2013cites this paper
• A phase II study of ixabepilone and trastuzumab for metastatic HER 2-positive breast cancer

  2013cites this paper
• Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial

  2013cites this paper
• Synthesis and Molecular Modeling Studies of Bicyclic Inhibitors of Dihydrofolate Reductase, Receptor Tyrosine Kinases and Tubulin

  2013cites this paper
• Altered TUBB3 expression contributes to the epothilone response of mitotic cells

  2013cites this paper
• Total synthesis of epothilone D: the nerol/macroaldolization approach.

  2013cites this paper
• Asymmetric Hydrogenation of CO and CN Bonds in Stereoselective Synthesis

  2013cites this paper
• Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression

  2012cites this paper
• NMR in natural products: understanding conformation, configuration and receptor interactions.

  2012cites this paper
• Cytoskeleton and Human Disease

  2012cites this paper
• Comparative Binding Energy (COMBINE) Analysis Supports a Proposal for the Binding Mode of Epothilones to β‐Tubulin

  2012cites this paper
• Synthesis and biological evaluation of open-chain epothilones

  2012cites this paper
• New Therapeutic Options for Chemotherapy-Resistant Metastatic Breast Cancer

  2012cites this paper
• Experiencia con ixabepilona como tratamiento de primera línea para el cáncer de mama metastásico en América Latina

  2012cites this paper
• Epothilones in development for non--small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistance.

  2012cites this paper
• Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles.

  2012cites this paper
• Microtubules as a Target in Cancer Therapy

  2012cites this paper
• Structural insight into the mechanism of epothilone A bound to beta-tubulin and its mutants at Arg282Gln and Thr274Ile

  2012cites this paper
• Current and Next Generation Antimitotic Therapies in Cancer

  2012cites this paper
• Taxanes and Epothilones in Cancer Treatment

  2011cites this paper
• Malignant disease of the breast

  2011cites this paper
• Review article Epothilones in prostate cancer

  2011cites this paper
• Computational study of binding of epothilone A to β-tubulin.

  2011cites this paper
• ADVANCES IN BREAST CANCER THERAPY AND CHEMOPREVENTION: CURRENT STRATEGIES AND NOVEL TARGETS

  2011cites this paper
• Prostate Cancer: Current and Emerging Therapies

  2011cites this paper
• Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients

  2011cites this paper
• Epothilones in prostate cancer.

  2011cites this paper
• 12-Aza-Epothilones

  2011cites this paper
• Epothilones in the treatment of ovarian cancer.

  2011cites this paper
• Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives

  2011influential citation
• Alternative dosing schedules and administration updates for Ixabepilone

  2011cites this paper
• C6-C8 bridged epothilones: consequences of installing a conformational lock at the edge of the macrocycle.

  2011cites this paper
• Highlights of natural compounds in prostate cancer drug discovery

  2011cites this paper
• Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone

  2010cites this paper
• Targeting Abeta and tau in Alzheimer's disease, an early interim report.

  2010cites this paper
• Evaluation of Novel Epothilone Analogues by means of a Common Pharmacophore and a QSAR Pseudoreceptor Model for Taxanes and Epothilones

  2010cites this paper
• Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer

  2010cites this paper
• Present and future evolution of advanced breast cancer therapy

  2010cites this paper
• Implications of Anthracycline‐Resistant and Taxane‐Resistant Metastatic Breast Cancer and New Therapeutic Options

  2010cites this paper
• Ixabepilone, a New Treatment Option for Metastatic Breast Cancer

  2010influential citation
• Interaction of epothilone B (patupilone) with microtubules as detected by two-dimensional solid-state NMR spectroscopy.

  2010cites this paper
• Visceral disease in patients with metastatic breast cancer: efficacy and safety of treatment with ixabepilone and other chemotherapeutic agents.

  2010cites this paper
• Total synthesis and evaluation of C26-hydroxyepothilone D derivatives for photoaffinity labeling of beta-tubulin.

  2010cites this paper
• Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines.

  2010cites this paper
• Patient Access to Cancer Drugs in Turkey July , 2010

  2010cites this paper
• Current therapies and novel targets in treatment of breast cancer

  2010cites this paper
• Paclitaxel and Epothilone Analogues, Anticancer Drugs

  2010cites this paper
• New tariquidar-like ABCB1 modulators in cancer chemotherapy:Preclinical pharmacokinetic, pharmacodynamic investigations and computational studies

  2010cites this paper
• Microtubule Targeting Agents

  2010cites this paper
• 3.02 – Natural Products as Lead Sources for Drug Development

  2010cites this paper
• Synthesis of epothilones molecule fragment (15R)-C13-C21 from D-mannitol

  2010cites this paper
• The Binding Mode of Side Chain‐ and C3‐Modified Epothilones to Tubulin

  2010cites this paper
• Long-Lasting Control of Triple-Negative Metastatic Breast Cancer with the Novel Drug Combination Ixabepilone and Capecitabine – Case Report

  2010cites this paper
• Development of novel agents for bladder cancer

  2009cites this paper
• Epothilones: tubulin polymerization as a novel target for prostate cancer therapy

  2009cites this paper
• Aziridine alkaloids as potential therapeutic agents.

  2009cites this paper
• Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer.

  2009cites this paper
• From nature to the laboratory and into the clinic.

  2009cites this paper
• Epothilone analogues with benzimidazole and quinoline side chains: chemical synthesis, antiproliferative activity, and interactions with tubulin.

  2009cites this paper
• Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy

  2009cites this paper
• Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.

  2009cites this paper
• Total synthesis of epothilones A-F.

  2009cites this paper
• Cytoskeleton structure and dynamic behaviour: quick excursus from basic molecular mechanisms to some implications in cancer chemotherapy.

  2009cites this paper
• Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies.

  2009cites this paper
• Therapeutic options for metastatic breast cancer

  2009cites this paper
• An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.

  2009cites this paper
• New Options for the Treatment of Relapsed Mantle Cell Lymphoma

  2009cites this paper